Latest Trials

Systemic therapy trial

IMAGO MF : A Multi-Center, Open Label Study to Assess the Safety, Steady-State Pharmacokinetics and...

This phase I trial is evaluating an oral drug (IMG-7289) in patients with Myelofibrosis

Status : Recruiting

Systemic therapy trial

IKEMA : Randomized, Open Label, Multicenter Study Assessing The Clinical Benefit Of Isatuximab...

This phase III trial is evaluating whether the combination of two intravenous drugs (isatuximab and carfilzomib) and a steroid (dexamethasone) is better than carfilzomib and dexamethasone alone in patients with previously treated, advanced multiple myeloma

Status : Recruiting

Systemic therapy trial

SCOUT : A Phase 1/2 Study of the Oral TRK Inhibitor LOXO-101 (Larotrectinib) in Pediatric...

This phase I/II trial is using an oral drug (LOXO-101) as a treatment in children and adolescents with central nervous system tumours

Status : Recruiting

Systemic therapy trial

OZM-063 : A Phase II, Open-Labeled, Multi-Center, Randomized Controlled Trial of Vinblastine +/-...

This phase II trial is trying to determine the benefit of adding Bevacizumab (an intravenous drug) to chemotherapy treatment with Vinblastine, in children and adolescents with low grade gliomas

Status : Recruiting

Systemic therapy trial

BIOMEDE : Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication

This phase II trial is testing three oral drugs (Erlotinib, Everolimus and Dasatinib) as a possible treatment for Diffuse Intrinsic Pontine Glioma (DIPG)

Status : Recruiting

Systemic therapy trial

M13-833 : A Phase 1 Study of the Safety and Pharmacokinetics of Venetoclax in Pediatric and Young...

This phase I trial is evaluating an oral drug (venetoclax) with or without chemotherapy in children and young adults with relapsed or refractory malignancies

Status : Recruiting

Systemic therapy trial

AAML1331 : A Phase III Study for Patients With Newly Diagnosed Acute Promyelocytic Leukemia (APL)...

This phase III trial is evaluating tretinoin and arsenic trioxide for the treatment of patients with newly diagnosed Acute Promyelocytic Leukemia

Status : Recruiting

Systemic therapy trial

BLAM : A phase IIb study of Blinatumomab + Cytarabine (AraC) and Methotrexate in adult...

This phase II trial is evaluating a biological and chemotherapy treatment protocol (Blinatumomab + Cytarabine (AraC) and Methotrexate) for patients with Acute Lymphoblastic Leukaemia

Status : Recruiting

Systemic therapy trial

A Phase 3 Randomized Double-Blind Placebo-Controlled Study Investigating the Efficacy and...

This phase III trial is evaluating a treatment for anaemia in patients with lower risk Myelodysplastic Syndrome (MDS) and low red blood cell (RBC) transfusion burden (LTB)

Status : Recruiting

Multiple treatment types

AZTEC : A Randomised Phase II Trial Comparing the Efficacy of Single-fraction or Multi-fraction...

This phase II trial is evaluating radiotherapy and immunotherapy for the treatment of advanced triple negative breast cancer (TNBC)

Status : Recruiting

 

Looking for a trial? Use the search functionality to find the trial you are finding.